Editas Medicine (EDIT) Other Operating Expenses (2016 - 2020)
Editas Medicine (EDIT) reported Other Operating Expenses of $2000.0 for Q4 2020, up 100.0% year-over-year from $1000.0 in Q1 2020, and up 100.0% on a QoQ basis from $1000.0 in Q4 2019.
Editas Medicine (EDIT) has 4 years of Other Operating Expenses data on file, last reported at $2000.0 in Q4 2020.
- Quarterly Other Operating Expenses rose 100.0% year-over-year to $2000.0 in Q4 2020, while the trailing twelve-month figure through Sep 2021 was $2000.0 (up 100.0% YoY) and the FY2016 annual result came in at $40.5 million, changed N/A from the prior year.
- Other Operating Expenses grew to $2000.0 in Q4 2020 per EDIT's latest filing, from $1000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $40.1 million in Q4 2017 and bottomed at $1000.0 in Q4 2019.
- The 4-year median for Other Operating Expenses is $5.2 million (2016), against an average of $12.6 million.
- The widest annual swing landed in 2017, when Other Operating Expenses jumped 288.09%; it then surged 100.0% in 2020.
- Tracing EDIT's Other Operating Expenses over 4 years: stood at $10.3 million in 2016, then jumped by 288.09% to $40.1 million in 2017, then tumbled by 100.0% to $1000.0 in 2019, then surged by 100.0% to $2000.0 in 2020.
- Per Business Quant, the three latest EDIT Other Operating Expenses figures stand at $2000.0 (Q4 2020), $1000.0 (Q4 2019), and $40.1 million (Q4 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Editas Medicine | 338.62 Mn | 338.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2017 | 40.11 Mn |
| Dec 31, 2016 | 10.34 Mn |